Marutani, Eizo
Miranda, Maria https://orcid.org/0000-0002-0817-553X
Durham, Timothy J. https://orcid.org/0000-0003-2056-4199
Kim, Sharon H.
Russell, Dreson L. https://orcid.org/0009-0008-6808-4163
Wiesenthal, Presli P.
Lichtenegger, Paul https://orcid.org/0000-0002-3171-794X
Menard, Marissa A. https://orcid.org/0000-0002-0976-3448
Brzozowski, Charlotte F. https://orcid.org/0000-0002-8871-2453
Li, Haobo https://orcid.org/0000-0002-5660-7835
Ruvkun, Gary
Meisel, Joshua D.
Volpicelli-Daley, Laura
Mootha, Vamsi K. https://orcid.org/0000-0001-9924-642X
Ichinose, Fumito https://orcid.org/0000-0003-4535-1632
Funding for this research was provided by:
Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital
Deutsche Forschungsgemeinschaft (431313887)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753, T32GM144273, K99GM140217)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R56NS117465, R01NS124679)
Howard Hughes Medical Institute
Marriott Foundation
Max Kade Foundation
Article History
Received: 16 January 2023
Accepted: 4 June 2025
First Online: 6 August 2025
Competing interests
: V.K.M. is listed as an inventor on patents filed by MGH on the therapeutic uses of hypoxia. V.K.M. is a paid adviser to 5AM Ventures and Falcon Bio.